AIMS: Glyceryl trinitrate (GTN) is the most commonly used anti-anginal agent, yet its mechanism of action has still to be fully established. Release of nitric oxide (NO) and the selectivity of GTN in the venous system are believed to be crucial to this drug's anti-anginal action. METHODS: Rat superior mesenteric arteries and renal veins were mounted in a wire myograph with an intraluminal NO microsensor. RESULTS: In the superior mesenteric arteries, GTN (1 nM to 10 microM) produced a dose-dependent vasodilatation without NO release, except at concentrations supramaximal for relaxation. GTN was found to be markedly less potent in a wide range of veins tested, and lowering the oxygen concentrations in the myograph to that of the venous system did not improve the venodilator activity of GTN. CONCLUSION: This is the first time that NO release from GTN has been monitored electrochemically in real time, simultaneously with vasodilatation. Unlike the endothelium-dependent vasodilator carbachol, NO could only be measured at concentrations of GTN that are supramaximal for relaxation. GTN was found to be arterioselective in vitro, even when oxygen levels were lowered to mimic those of the venous system in vivo. 2008 S. Karger AG, Basel.
AIMS: Glyceryl trinitrate (GTN) is the most commonly used anti-anginal agent, yet its mechanism of action has still to be fully established. Release of nitric oxide (NO) and the selectivity of GTN in the venous system are believed to be crucial to this drug's anti-anginal action. METHODS:Rat superior mesenteric arteries and renal veins were mounted in a wire myograph with an intraluminal NO microsensor. RESULTS: In the superior mesenteric arteries, GTN (1 nM to 10 microM) produced a dose-dependent vasodilatation without NO release, except at concentrations supramaximal for relaxation. GTN was found to be markedly less potent in a wide range of veins tested, and lowering the oxygen concentrations in the myograph to that of the venous system did not improve the venodilator activity of GTN. CONCLUSION: This is the first time that NO release from GTN has been monitored electrochemically in real time, simultaneously with vasodilatation. Unlike the endothelium-dependent vasodilator carbachol, NO could only be measured at concentrations of GTN that are supramaximal for relaxation. GTN was found to be arterioselective in vitro, even when oxygen levels were lowered to mimic those of the venous system in vivo. 2008 S. Karger AG, Basel.
Authors: Marissa Opelt; Gerald Wölkart; Emrah Eroglu; Markus Waldeck-Weiermair; Roland Malli; Wolfgang F Graier; Alexander Kollau; John T Fassett; Astrid Schrammel; Bernd Mayer; Antonius C F Gorren Journal: Mol Pharmacol Date: 2018-01-22 Impact factor: 4.436
Authors: Nora Gatzke; Philipp Hillmeister; André Dülsner; Nadija Güc; Rica Dawid; Katherine H Smith; Nikolaos Pagonas; Peter Bramlage; Michaela Gorath; Ivo R Buschmann Journal: PLoS One Date: 2018-08-17 Impact factor: 3.240
Authors: M Verena Wenzl; Matteo Beretta; Antonius C F Gorren; Andreas Zeller; Pravas K Baral; Karl Gruber; Michael Russwurm; Doris Koesling; Kurt Schmidt; Bernd Mayer Journal: J Biol Chem Date: 2009-06-08 Impact factor: 5.157
Authors: Matteo Beretta; Antonius C F Gorren; M Verena Wenzl; Robert Weis; Michael Russwurm; Doris Koesling; Kurt Schmidt; Bernd Mayer Journal: J Biol Chem Date: 2009-11-11 Impact factor: 5.157
Authors: Marissa Opelt; Emrah Eroglu; Markus Waldeck-Weiermair; Michael Russwurm; Doris Koesling; Roland Malli; Wolfgang F Graier; John T Fassett; Astrid Schrammel; Bernd Mayer Journal: J Biol Chem Date: 2016-09-27 Impact factor: 5.157